CCM2 and cancer: CA patients including within the discovery cohort harboring (1) multiple lesions throughout the brain on T2-weighted imaging or SWI, (2) a documented CCM1, CCM2, or CCM3 germline mutation, and/or (3) first-degree relative with a history of CA were classified as familial-CA (n = 25).